These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32715593)

  • 1. Tumour-capsule interface measured on 18F-DCFPyL PSMA positron emission tomography/CT imaging comparable to multi-parametric MRI in predicting extra-prostatic extension of prostate cancer at initial staging.
    Brauchli D; Singh D; Chabert C; Somasundaram A; Collie L
    J Med Imaging Radiat Oncol; 2020 Dec; 64(6):829-838. PubMed ID: 32715593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-Head Comparison of
    Exterkate L; Hermsen R; Küsters-Vandevelde HVN; Prette JF; Baas DJH; Somford DM; van Basten JA
    Eur Urol Oncol; 2023 Dec; 6(6):574-581. PubMed ID: 37230883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
    Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
    BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Magnetic Resonance Imaging and Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prediction of Extraprostatic Extension of Prostate Cancer and Surgical Guidance: A Prospective Nonrandomized Clinical Trial.
    Bahler CD; Tachibana I; Tann M; Collins K; Swensson JK; Green MA; Mathias CJ; Tong Y; Yong C; Boris RS; Brocken E; Hutchins GD; Sims JB; Hill DV; Smith N; Ferari C; Love H; Koch MO
    J Urol; 2024 Aug; 212(2):290-298. PubMed ID: 38785259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Head-to-Head Comparison of
    Sonni I; Felker ER; Lenis AT; Sisk AE; Bahri S; Allen-Auerbach M; Armstrong WR; Suvannarerg V; Tubtawee T; Grogan T; Elashoff D; Eiber M; Raman SS; Czernin J; Reiter RE; Calais J
    J Nucl Med; 2022 Jun; 63(6):847-854. PubMed ID: 34649942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective analysis of clinically significant prostate cancer detection with [
    Bodar YJL; Zwezerijnen BGJC; van der Voorn PJ; Jansen BHE; Smit RS; Kol SQ; Meijer D; de Bie K; Yaqub M; Windhorst BAD; Hendrikse HNH; Vis AN; Oprea-Lager DE
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1731-1742. PubMed ID: 34725727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of
    Tang Y; Ji X; Lin Q; Huang H; Zhu H; Huang X; Xie H; Chen W; Zhuang Y
    World J Urol; 2023 Apr; 41(4):1017-1024. PubMed ID: 36932282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal radiomics based on 18F-Prostate-specific membrane antigen-1007 PET/CT and multiparametric MRI for prostate cancer extracapsular extension prediction.
    Pan K; Yao F; Hong W; Xiao J; Bian S; Zhu D; Yuan Y; Zhang Y; Zhuang Y; Yang Y
    Br J Radiol; 2024 Feb; 97(1154):408-414. PubMed ID: 38308032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Evaluation of
    Gaur S; Mena E; Harmon SA; Lindenberg ML; Adler S; Ton AT; Shih JH; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Mease RC; Pomper MG; Choyke PL; Turkbey B
    AJR Am J Roentgenol; 2020 Sep; 215(3):652-659. PubMed ID: 32755168
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of preoperative locoregional Ga-68 PSMA-11 PET-CT and mp-MRI results with postoperative histopathology of prostate cancer.
    Yilmaz B; Turkay R; Colakoglu Y; Baytekin HF; Ergul N; Sahin S; Tugcu V; Inci E; Tasci AI; Cermik TF
    Prostate; 2019 Jun; 79(9):1007-1017. PubMed ID: 31012125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and localisation of primary prostate cancer using
    Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
    BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 68Ga-PSMA PET/CT and mp-MRI in regard to local staging for prostate cancer with histopathological results: A retrospective study.
    Ucar T; Gunduz N; Demirci E; Culpan M; Gunel H; Kir G; Atis RG; Yildirim A
    Prostate; 2022 Nov; 82(15):1462-1468. PubMed ID: 35915579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer.
    Amin A; Blazevski A; Thompson J; Scheltema MJ; Hofman MS; Murphy D; Lawrentschuk N; Sathianathen N; Kapoor J; Woo HH; Chalasani V; Rasiah K; van Leeuwen PJ; Tang R; Cusick T; Stricker P; Emmett L
    BJU Int; 2020 Apr; 125(4):515-524. PubMed ID: 31957122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of
    Coşar U; Şen İ; Aydos U; Koparal MY; Uçar M; Tokgöz N; Gönül İI; Akdemir ÜÖ; Atay LÖ; Sözen TS
    Int J Clin Pract; 2021 Aug; 75(8):e14287. PubMed ID: 33931929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEDAL protocol: a prospective single-arm paired comparison of multiparametric MRI and 18F-DCPFyl PSMA PET/CT to diagnose prostate cancer.
    Tran V; Hong A; Sutherland T; Taubman K; Lee SF; Lenaghan D; Sethi K; Corcoran NM; Lawrentschuk N; Woo H; Tarlinton L; Bolton D; Spelman T; Thomas L; Booth R; Hegarty J; Perry E; Wong LM
    BMJ Open; 2022 Sep; 12(9):e061815. PubMed ID: 36123093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Ga-PSMA PET MRI with mpMRI in localization and regional staging of prostate cancer.
    Deka H; Pooleri GK; Suguna B; Rajeshkannan R; Sekhar R; Bindhu MR; Prasad V
    World J Urol; 2024 Mar; 42(1):153. PubMed ID: 38483621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing extra-prostatic extension for surgical guidance in prostate cancer: Comparing two PSMA-PET tracers with the standard-of-care.
    Bahler CD; Green MA; Tann MA; Swensson JK; Collins K; Alexoff D; Kung H; Brocken E; Mathias CJ; Cheng L; Hutchins GD; Koch MO
    Urol Oncol; 2023 Jan; 41(1):48.e1-48.e9. PubMed ID: 36333187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of T staging in PI-RADS 4-5 prostate cancer by combination of multiparametric MRI and
    Ding Y; Mo C; Ding Q; Lin T; Gao J; Chen M; Lu W; Sun J; Wang F; Zang S; Zhang Q; Zhang S; Guo H
    BMC Urol; 2023 Dec; 23(1):206. PubMed ID: 38082379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework.
    Reynolds HM; Williams S; Jackson P; Mitchell C; Hofman MS; Hicks RJ; Murphy DG; Haworth A
    BJU Int; 2019 Jun; 123(6):1020-1030. PubMed ID: 30536698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.